Delivery Order SPE2DB22D2206-SPE2DB24FGE18
Award Date 3/19/24
Potential Completion Date 4/9/24
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XERMELO 250 MG TABLET 84S. The contract has a firm fixed price of $5,526.76 and a period of performance through July 23, 2025. This contract is not designated as a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides...
- The federal contract award is a delivery order with a firm fixed price of $5,526.76 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XERMELO 250 MG TABLET 84S to the Defense Logistics Agency, a defense agency. The award has an ultimate completion date of July 28, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,775.56 Firm Fixed Price Delivery Order is for the provision of 4566736117 XERMELO 250 MG TABLET 84S, a specialty medication. The contract has an ultimate completion date of January 8, 2025 and was awarded on December 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Xermelo 250 mg tablets (84-count). This firm fixed-price delivery order, valued at $5,526.76, represents a non-set-aside competitive award with an ultimate completion date of September 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xermelo 250 mg tablets (84-count) on September 9, 2025, with a ceiling value of $11,053.54 and an ultimate completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug...
- This federal contract award SPE2DB22D2206|SPE2DB24FHD69 was made by the Defense Logistics Agency (DLA), a defense agency, to the Corporate Office division of Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $9,232.06 firm-fixed-price delivery order is for the pharmaceutical product XERMELO 250 MG TABLET 84S. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product XELJANZ XR 11 MG TABLET. The award has a potential value of $3,207.44 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XELJANZ XR 11 mg tablets. The potential value of this delivery order is $3,014.72 and the period of performance extends through February 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, with a potential value of $5,920.84 and a completion date of December 20, 2023. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products from its corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XELJANZ XR 11 MG TABLET UU 30S. This $1,879.09 contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. The company holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves...